Medicenna Therapeutics Corp.
MDNA.TO
TSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -72.86% | -128.92% | -198.13% | -147.31% | -56.08% |
Total Depreciation and Amortization | 807.14% | 371.43% | 61.11% | -3.45% | -67.06% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1,332.04% | 340.17% | 255.25% | 266.38% | 85.47% |
Change in Net Operating Assets | -119.06% | -112.15% | 13.32% | -70.05% | 13.93% |
Cash from Operations | -17.64% | -25.03% | -8.05% | -26.01% | 0.05% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | 16,005.15% | -12.86% | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 12,377.81% | 40,072.41% | -16.25% | -- | -100.73% |
Foreign Exchange rate Adjustments | 310.54% | 98.06% | -30.63% | -135.36% | -148.43% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 155.88% | 131.84% | -47.79% | -221.12% | -208.79% |